Blackhawk Growth, an investment holding company, is acquiring MindBio Therapeutics

MindBio Therapeutics (www.MindBioTherapeutics.com), an arms-length, privately held clinical stage drug development company, is pioneering psychedelic micro-dosing research and is advancing emerging therapies to treat a range of debilitating health conditions such as depression, anxiety, chronic pain, cognitive impairment and PTSD.

source